ARTV

Healthcare

Artiva Biotherapeutics, Inc.

$6.12-0.63 (-9.33%)

Prev Close

$6.75

Open

$6.65

High

$6.76

Low

$5.95

Volume

193.0K

Market Cap

$140.2M

P/E

—

Div Yield

—

Over the past 12 months, insider activity at Artiva Biotherapeutics, Inc. (ARTV) has been exclusively selling, with 0 insider purchases totaling $0.00 and 16 insider sales totaling $484.3K. The most recent insider transaction was by Aslan Fred (President and CEO), who sold $58.4K worth of shares on Feb 15, 2026. Artiva Biotherapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $140.2M.

Buys (12M)

$0.00

Sells (12M)

$484.3K

Net Activity

Net Seller

$484.3K

Active Insiders

last 12 mo

ARTV Price Chart

ARTV Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value
Feb 15, 2026↗	Aslan Fred	President and CEO	Sell	14,600	$4.00	$58.4K
Feb 15, 2026↗	Bush Jennifer	COO, CLO, Secy, Compliance Off	Sell	3,515	$4.00	$14.1K
Feb 15, 2026↗	Horan Christopher	Chief Tech Operations Officer	Sell	2,187	$4.00	$8.7K
Feb 15, 2026↗	Raymon Heather	SVP, Research and Development	Sell	1,521	$4.00	$6.1K
Dec 15, 2025↗	Aslan Fred	President and CEO	Sell	3,187	$6.00	$19.1K
Nov 15, 2025↗	Aslan Fred	President and CEO	Sell	12,722	$3.31	$42.1K
Nov 15, 2025↗	Bush Jennifer	COO, CLO, Secy, Compliance Off	Sell	3,055	$3.25	$9.9K
Nov 15, 2025↗	Horan Christopher	Chief Tech Operations Officer	Sell	1,899	$3.25	$6.2K
Nov 15, 2025↗	Krishnamohan Neha	Chief Financial Officer	Sell	3,490	$3.25	$11.3K
Nov 15, 2025↗	Raymon Heather	SVP, Research and Development	Sell	1,375	$3.25	$4.5K
Oct 17, 2025↗	Aslan Fred	President and CEO	Sell	25,500	$6.00	$153.0K
May 15, 2025↗	Aslan Fred	President and CEO	Sell	34,444	$2.65	$91.4K
May 15, 2025↗	Bush Jennifer	COO, CLO, Secy, Compliance Off	Sell	8,346	$2.61	$21.8K
May 15, 2025↗	Horan Christopher	Chief Tech Operations Officer	Sell	4,918	$2.58	$12.7K
May 15, 2025↗	Krishnamohan Neha	Chief Financial Officer	Sell	7,154	$2.63	$18.8K
May 15, 2025↗	Raymon Heather	SVP, Research and Development	Sell	2,384	$2.56	$6.1K
Jul 22, 2024↗	Huh Yong-Jun	Director	Buy	2,083,332	$12.00	$25.00M

ARTV Insider Buying Activity

The following table shows recent insider purchases of Artiva Biotherapeutics, Inc. (ARTV) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jul 22, 2024↗	Huh Yong-Jun	Director	Buy	2,083,332	$12.00	$25.00M	0

ARTV Insider Selling Activity

The following table shows recent insider sales of Artiva Biotherapeutics, Inc. (ARTV) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value
Feb 15, 2026↗	Aslan Fred	President and CEO	Sell	14,600	$4.00	$58.4K
Feb 15, 2026↗	Bush Jennifer	COO, CLO, Secy, Compliance Off	Sell	3,515	$4.00	$14.1K
Feb 15, 2026↗	Horan Christopher	Chief Tech Operations Officer	Sell	2,187	$4.00	$8.7K
Feb 15, 2026↗	Raymon Heather	SVP, Research and Development	Sell	1,521	$4.00	$6.1K
Dec 15, 2025↗	Aslan Fred	President and CEO	Sell	3,187	$6.00	$19.1K
Nov 15, 2025↗	Aslan Fred	President and CEO	Sell	12,722	$3.31	$42.1K
Nov 15, 2025↗	Bush Jennifer	COO, CLO, Secy, Compliance Off	Sell	3,055	$3.25	$9.9K
Nov 15, 2025↗	Horan Christopher	Chief Tech Operations Officer	Sell	1,899	$3.25	$6.2K
Nov 15, 2025↗	Krishnamohan Neha	Chief Financial Officer	Sell	3,490	$3.25	$11.3K
Nov 15, 2025↗	Raymon Heather	SVP, Research and Development	Sell	1,375	$3.25	$4.5K
Oct 17, 2025↗	Aslan Fred	President and CEO	Sell	25,500	$6.00	$153.0K
May 15, 2025↗	Aslan Fred	President and CEO	Sell	34,444	$2.65	$91.4K
May 15, 2025↗	Bush Jennifer	COO, CLO, Secy, Compliance Off	Sell	8,346	$2.61	$21.8K
May 15, 2025↗	Horan Christopher	Chief Tech Operations Officer	Sell	4,918	$2.58	$12.7K
May 15, 2025↗	Krishnamohan Neha	Chief Financial Officer	Sell	7,154	$2.63	$18.8K
May 15, 2025↗	Raymon Heather	SVP, Research and Development	Sell	2,384	$2.56	$6.1K